Maternal glucose in pregnancy is associated with child's adiposity and leptin at 5 years of age.


Journal

Pediatric obesity
ISSN: 2047-6310
Titre abrégé: Pediatr Obes
Pays: England
ID NLM: 101572033

Informations de publication

Date de publication:
09 2021
Historique:
revised: 31 01 2021
received: 09 10 2020
accepted: 23 02 2021
pubmed: 18 3 2021
medline: 15 12 2021
entrez: 17 3 2021
Statut: ppublish

Résumé

Exposure to maternal hyperglycaemia in pregnancy has been associated with childhood obesity. Leptin regulation might be involved in this 'adiposity programming' and may depend on timing of exposure. To investigate associations of maternal glycaemia at different periods in pregnancy with childhood adiposity and leptin levels at 5 years of age. In a prospective pre-birth cohort, we measured maternal glucose levels after a 50 g oral glucose challenge test at first trimester (9.8 ± 2.3 weeks) and during a 75 g oral glucose tolerance test at second trimester (26.5 ± 0.9 weeks). We followed up children at 5 years; we measured anthropometry and body composition using dual-energy X-ray absorptiometry (DXA). We measured fasting leptin levels using immunoassays (Luminex) in 328 children. We conducted linear regression analyses, adjusting for potential confounders. Maternal glycaemia at first trimester was associated with childhood leptin levels at 5 years, independently of maternal pre-pregnancy BMI and other confounders (β = .09 ± .04; P = .03). Higher post-load glucose levels at second trimester were associated with greater total body fat percentage measured by DXA (1 hour-glucose: β = .010 ± .004; P = .03 and 2 hours-glucose: β = .016 ± .005; P = .002), but not with leptin levels. Our results suggest that programming of leptin regulation may be sensitive to maternal hyperglycaemia specifically in early pregnancy.

Sections du résumé

BACKGROUND
Exposure to maternal hyperglycaemia in pregnancy has been associated with childhood obesity. Leptin regulation might be involved in this 'adiposity programming' and may depend on timing of exposure.
OBJECTIVES
To investigate associations of maternal glycaemia at different periods in pregnancy with childhood adiposity and leptin levels at 5 years of age.
METHODS
In a prospective pre-birth cohort, we measured maternal glucose levels after a 50 g oral glucose challenge test at first trimester (9.8 ± 2.3 weeks) and during a 75 g oral glucose tolerance test at second trimester (26.5 ± 0.9 weeks). We followed up children at 5 years; we measured anthropometry and body composition using dual-energy X-ray absorptiometry (DXA). We measured fasting leptin levels using immunoassays (Luminex) in 328 children. We conducted linear regression analyses, adjusting for potential confounders.
RESULTS
Maternal glycaemia at first trimester was associated with childhood leptin levels at 5 years, independently of maternal pre-pregnancy BMI and other confounders (β = .09 ± .04; P = .03). Higher post-load glucose levels at second trimester were associated with greater total body fat percentage measured by DXA (1 hour-glucose: β = .010 ± .004; P = .03 and 2 hours-glucose: β = .016 ± .005; P = .002), but not with leptin levels.
CONCLUSIONS
Our results suggest that programming of leptin regulation may be sensitive to maternal hyperglycaemia specifically in early pregnancy.

Identifiants

pubmed: 33728816
doi: 10.1111/ijpo.12788
doi:

Substances chimiques

Blood Glucose 0
Leptin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12788

Subventions

Organisme : CIHR
ID : MOP-115071
Pays : Canada
Organisme : CIHR
ID : PJT-152989
Pays : Canada

Informations de copyright

© 2021 World Obesity Federation.

Références

Bianco ME, Josefson JL. Hyperglycemia during pregnancy and long-term offspring outcomes. Curr Diab Rep. 2019;19(12):143. https://doi.org/10.1007/s11892-019-1267-6.
Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci. 2018;19(11):3342. https://doi.org/10.3390/ijms19113342.
Steculorum SM, Bouret SG. Maternal diabetes compromises the organization of hypothalamic feeding circuits and impairs leptin sensitivity in offspring. Endocrinology. 2011;152(11):4171-4179. https://doi.org/10.1210/en.2011-1279.
Gogga P, Karbowska J, Meissner W. Role of leptin in the regulation of lipid and carbohydrate metabolism. Postep Hig Med Dosw Online. 2011;65:255-262.
Shi X, Huang P, Wang L, et al. Maternal postload 1-hour glucose level during pregnancy and offspring's overweight/obesity status in preschool age. BMJ Open Diabetes Res Care. 2020;8(1):6-8. https://doi.org/10.1136/bmjdrc-2019-000738.
Chang Y, Chen X, Zhang ZK. Intrauterine exposure to maternal diabetes is associated with adiposity in children at 6 years of age in China. Biomed Environ Sci. 2015;28(2):140-142. https://doi.org/10.3967/bes2015.017.
Landon MB, Mele L, Varner MW, et al. The relationship of maternal glycemia to childhood obesity and metabolic dysfunction‡. J Matern Neonatal Med. 2020;33(1):33-41. https://doi.org/10.1080/14767058.2018.1484094.
Lowe WL, Lowe LP, Kuang A, et al. Maternal glucose levels during pregnancy and childhood adiposity in the hyperglycemia and adverse pregnancy outcome follow-up study. Diabetologia. 2019;62(4):598-610. https://doi.org/10.1007/s00125-018-4809-6.
Wright CS, Rifas-Shiman SL, Rich-Edwards JW, Taveras EM, Gillman MW, Oken E. Intrauterine exposure to gestational diabetes, child adiposity, and blood pressure. Am J Hypertens. 2009;22(2):215-220. https://doi.org/10.1038/ajh.2008.326.
Regnault N, Gillman MW, Rifas-Shiman SL, Eggleston E, Oken E. Sex-specific associations of gestational glucose tolerance with childhood body composition. Diabetes Care. 2013;36(10):3045-3053. https://doi.org/10.2337/dc13-0333.
Kearney M, Perron J, Marc I, Weisnagel SJ, Tchernof A, Robitaille J. Association of prenatal exposure to gestational diabetes with offspring body composition and regional body fat distribution. Clin Obes. 2018;8(2):81-87. https://doi.org/10.1111/cob.12237.
Wahab RJ, Voerman E, Jansen PW, et al. Maternal glucose concentrations in early pregnancy and cardiometabolic risk factors in childhood. Obesity. 2020;28(5):985-993. https://doi.org/10.1002/oby.22771.
Chandler-Laney PC, Mancuso MS, Bush NC, Gower BA, Rouse DJ. Maternal glucose concentration during pregnancy predicts fat and lean mass of prepubertal offspring. Diabetes Care. 2011;34(3):741-745. https://doi.org/10.2337/dc10-1503.
Pettitt DJ, McKenna S, McLaughlin C, Patterson CC, Hadden DR, McCance DR. Maternal glucose at 28 weeks of gestation is not associated with obesity in 2-year-old offspring: the Belfast hyperglycemia and adverse pregnancy outcome (HAPO) family study. Diabetes Care. 2010;33(6):1219-1223. https://doi.org/10.2337/dc09-2384.
Gagné-Ouellet V, Breton E, Thibeault K, et al. Mediation analysis supports a causal relationship between maternal hyperglycemia and placental dna methylation variations at the leptin gene locus and cord blood leptin levels. Int J Mol Sci. 2020;21(1):1-13. https://doi.org/10.3390/ijms21010329.
West J, Santorelli G, Whincup PH, et al. Association of maternal exposures with adiposity at age 4/5 years in white British and Pakistani children: findings from the born in Bradford study. Diabetologia. 2018;61(1):242-252. https://doi.org/10.1007/s00125-017-4457-2.
Lawlor DA, West J, Fairley L, et al. Pregnancy glycaemia and cord-blood levels of insulin and leptin in Pakistani and white British mother-offspring pairs: findings from a prospective pregnancy cohort. Diabetologia. 2014;57(12):2492-2500. https://doi.org/10.1007/s00125-014-3386-6.
Allard C, Desgagné V, Patenaude J, et al. Mendelian randomization supports causality between maternal hyperglycemia and epigenetic regulation of leptin gene in newborns. Epigenetics. 2015;10(4):342-351. https://doi.org/10.1080/15592294.2015.1029700.
Ott R, Stupin JH, Loui A, et al. Maternal overweight is not an independent risk factor for increased birth weight, leptin and insulin in newborns of gestational diabetic women: observations from the prospective “EaCH” cohort study. BMC Pregnancy Childbirth. 2018;18(1):1-18. https://doi.org/10.1186/s12884-018-1889-8.
West NA, Crume TL, Maligie MA, Dabelea D. Cardiovascular risk factors in children exposed to maternal diabetes in utero. Diabetologia. 2011;54(3):504-507. https://doi.org/10.1007/s00125-010-2008-1.
Kampmann FB, Thuesen ACB, Hjort L, et al. Increased leptin, decreased adiponectin and FGF21 concentrations in adolescent offspring of women with gestational diabetes. Eur J Endocrinol. 2019;181(6):691-700.
Hivert MF, Rifas-Shiman SL, Gillman MW, Oken E. Greater early and mid-pregnancy gestational weight gains are associated with excess adiposity in mid-childhood. Obesity. 2016;24(7):1546-1553. https://doi.org/10.1002/oby.21511.
Guillemette L, Allard C, Lacroix M, et al. Genetics of glucose regulation in gestation and growth (Gen3G): a prospective prebirth cohort of mother-child pairs in Sherbrooke, Canada. BMJ Open. 2016;6(2):e010031. https://doi.org/10.1136/bmjopen-2015-010031.
World Health Organization. WHO|Application tools. https://www.who.int/growthref/tools/en/. Accessed September 8, 2020.
Schmelzle HR, Fusch C. Body fat in neonates and young infants: validation of skinfold thickness versus dual-energy X-ray absorptiometry. Am J Clin Nutr. 2002;76(5):1096-1100. https://doi.org/10.1093/ajcn/76.5.1096.
R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. 2020. https://www.r-project.org/
Stiles J, Jernigan TL. The basics of brain development. Neuropsychol Rev. 2010;20(4):327-348. https://doi.org/10.1007/s11065-010-9148-4.
Márquez-Valadez B, Valle-Bautista R, García-López G, Díaz NF, Molina-Hernández A. Maternal diabetes and fetal programming toward neurological diseases: beyond neural tube defects. Front Endocrinol (Lausanne). 2018;9:664. https://doi.org/10.3389/fendo.2018.00664.
Money KM, Barke TL, Serezani A, et al. Gestational diabetes exacerbates maternal immune activation effects in the developing brain. Mol Psychiatry. 2018;23(9):1920-1928. https://doi.org/10.1038/mp.2017.191.
Lindsay KL, Buss C, Wadhwa PD, Entringer S. The interplay between nutrition and stress in pregnancy: implications for fetal programming of brain development. Biol Psychiatry. 2019;85(2):135-149. https://doi.org/10.1016/j.biopsych.2018.06.021.
Poissonnet CM, Burdi AR, Bookstein FL. Growth and development of human adipose tissue during early gestation. Early Hum Dev. 1983;8(1):1-11. https://doi.org/10.1016/0378-3782(83)90028-2.
Hansen NS, Strasko KS, Hjort L, et al. Fetal hyperglycemia changes human preadipocyte function in adult life. J Clin Endocrinol Metab. 2017;102(4):1141-1150. https://doi.org/10.1210/jc.2016-3907.
Houshmand-Oeregaard A, Hansen NS, Hjort L, et al. Differential adipokine DNA methylation and gene expression in subcutaneous adipose tissue from adult offspring of women with diabetes in pregnancy. Clin Epigenetics. 2017;9(1):37. https://doi.org/10.1186/s13148-017-0338-2.

Auteurs

Kasandra Blais (K)

Faculty of Medicine and Health Sciences, Department of Medicine, Université de Sherbrooke, Sherbrooke, Québec, Canada.

Mélina Arguin (M)

Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Québec, Canada.

Catherine Allard (C)

Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Québec, Canada.

Myriam Doyon (M)

Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Québec, Canada.

Vernon W Dolinsky (VW)

Department of Pharmacology and Therapeutics, Children's Hospital Research Institute of Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada.

Luigi Bouchard (L)

Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Québec, Canada.
Faculty of Medicine and Health Sciences, Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Department of Medical Biology, CIUSSS of Saguenay-Lac-Saint-Jean, Saguenay, Québec, Canada.

Marie-France Hivert (MF)

Faculty of Medicine and Health Sciences, Department of Medicine, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Québec, Canada.
Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, USA.
Diabetes Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.

Patrice Perron (P)

Faculty of Medicine and Health Sciences, Department of Medicine, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Québec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH